NLG
New Legacy Group Portfolio holdings
AUM
$36.6M
This Quarter Return
+3.18%
1 Year Return
+36.77%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$38.8M
AUM Growth
+$38.8M
(-21%)
Cap. Flow
-$13.8M
Cap. Flow
% of AUM
-35.54%
Top 10 Holdings %
Top 10 Hldgs %
80.15%
Holding
28
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Rivian
RIVN
|
$13.4M |
| 2 |
Apple
AAPL
|
$166K |
| 3 |
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
|
$144K |
| 4 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
$61K |
Sector Composition
| 1 | Consumer Discretionary | 23.48% |
| 2 | Communication Services | 10.69% |
| 3 | Technology | 7.21% |
| 4 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares US Consumer Discretionary ETF
IYC
$1.72B
| $244K | 0.63% |
4,200
| – | – |
|
27
SPDR S&P Biotech ETF
XBI
$5.07B
| $222K | 0.57% |
2,805
| – | – |
|
|
PHAS
28
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| – | – |
-240,575
| Closed | -$144K |
|